This brand name is authorized in Nigeria.
The drug OSTEOFLEX ULTRA contains one active pharmaceutical ingredient (API):
1
|
UNII
S270N0TRQY - HYALURONIC ACID
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A11-100699 | Caplet | OSTEOFLEX ULTRA CAPLET TAB 158 | 36 NF-PP-388982 OSTEOFLEX ULTRA CAPLET HYALURONIC ACID, CARTILAGE BLEND, BORON A11-100699 Drugs MUSCULO-SKELETAL SYSTEM Nigerian Products 158 Over The Counter (OTC) 11/24/2023 UNITED AFRICAN LABORATORY LIMITED, TEBUN BISIRIYU STREET, SHASHA, LAGOS IKEJA LAGOS 8181519968 ualafrica@yahoo.com ECOMED PHARMA LIMIED, PLOT 32, LYNSON CHEMICAL AVENUE, KM 38, LAGOS ABEOKUTA, SANGO OTA, OGUN STATE., Nigeria | 30/04/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
M09AX01 | Hyaluronic acid | M Musculo-skeletal system → M09 Other drugs for disorders of the musculo-skeletal system → M09A Other drugs for disorders of the musculo-skeletal system → M09AX Other drugs for disorders of the musculo-skeletal system |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A11-100699 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.